Cross Country Healthcare (CCRN)
Supplies nurses, allied clinicians, physicians, and workforce tools to U.S. healthcare employers.
$13.25
0.00 (0.00%)
Delisted · Jul 22, 2026
In millions of USD, except per-share figures
| In millions | Q2 FY23Jun 2023 | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 541 | 442 | 414 | 379 | 340 | 315 | 310 | 293 | 274 | 250 | 237 | 241 |
| Cost of revenue | 418 | 345 | 324 | 302 | 269 | 251 | 248 | 235 | 218 | 199 | 189 | 197 |
| Gross profit | 123 | 97 | 90 | 77 | 71 | 64 | 62 | 59 | 56 | 51 | 48 | 44 |
| 88 | 77 | 77 | 74 | 90 | 61 | 65 | 60 | 62 | 57 | 55 | 46 | |
| 0 | 70 | 72 | 0 | 0 | 54 | 55 | 52 | 50 | 0 | 51 | 46 | |
| Selling & marketing | 0 | 0 | 12 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 60 | 0 | 0 | 0 | 47 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 88 | 7 | 5 | 74 | 90 | 7 | 10 | 7 | 12 | 57 | 4 | 0 |
| Operating income | 35 | 20 | 13 | 3 | −19 | 3 | −3 | −1 | −6 | −6 | −7 | −2 |
| −5 | −1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | −64 | −2 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest expense | 3 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | −1 | 0 | −1 | −5 | −6 | −1 | −4 | −1 | −1 | −1 | 64 | 1 |
| Income before tax | 30 | 20 | 13 | 4 | −20 | 3 | −4 | −1 | −6 | −6 | −71 | −4 |
| Income tax expense | 9 | 7 | 4 | 1 | −4 | 1 | 0 | 0 | 1 | −1 | 12 | 1 |
| Net income from continuing operations | 21 | 13 | 9 | 3 | −16 | 3 | −4 | 0 | −7 | −5 | −83 | −4 |
| Net income | 21 | 13 | 9 | 3 | −16 | 3 | −4 | 0 | −7 | −5 | −83 | −4 |
| EPS, basic | $0.60 | $0.37 | $0.26 | $0.08 | −$0.47 | $0.08 | −$0.12 | −$0.02 | −$0.20 | −$0.15 | −$2.56 | −$0.14 |
| EPS, diluted | $0.60 | $0.36 | $0.26 | $0.08 | −$0.47 | $0.08 | −$0.12 | −$0.02 | −$0.20 | −$0.15 | −$2.56 | −$0.14 |
| Weighted average shares, basic | 35 | 35 | 34 | 34 | 34 | 33 | 32 | 32 | 32 | 33 | 32 | 31 |
| Weighted average shares, diluted | 36 | 35 | 35 | 35 | 34 | 33 | 32 | 32 | 32 | 33 | 32 | 31 |
| EBITDA | 41 | 25 | 18 | 13 | −8 | 8 | 4 | 4 | −1 | −1 | −67 | 1 |
| Depreciation & amortization | 4 | 5 | 4 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 4 |
| EBIT | 37 | 20 | 14 | 8 | −13 | 4 | 0 | 0 | −5 | −5 | −71 | −3 |